BioVie Inc. Net Investment Income
BioVie Inc. (BIVI) reported Net Investment Income of -$118.13 thousand for the 9-month period ending 2013-12-31, per its 10-Q filed 2014-01-29.
Discontinued › Income Statement › Other Income
us-gaap:NetInvestmentIncome · last filed 2014-01-29
- BioVie Inc. net investment income for the quarter ending 2013-12-31 was -$47.13K.
- BioVie Inc. net investment income for the quarter ending 2013-09-30 was -$53.49K.
| Period end | Net Investment Income 3 month | Net Investment Income 6 month | Net Investment Income 9 month |
|---|---|---|---|
| 2013-12-31 | -$47.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-29 | -$100.62K 10-Q · filed 2014-01-29 | -$118.13K 10-Q · filed 2014-01-29 |
| 2013-09-30 | -$53.49K 10-Q · filed 2013-11-13 | -$71.00K 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |